Home / Publications / Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates

Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates

Anna Alexandrovna Druzina 1
Anna Alexandrovna Druzina
Nadezhda Vadimovna Dudarova 1
Nadezhda Vadimovna Dudarova
Olga Borisovna Zhidkova 1
Olga Borisovna Zhidkova
Ivan Alekseevich Razumov 2
Ivan Alekseevich Razumov
Olga Igorevna Solovieva 2
Olga Igorevna Solovieva
Vladimir Vladimirovich Kanygin
Vladimir Iosifovich Bregadze 1
Vladimir Iosifovich Bregadze
Published 2022-04-29
CommunicationVolume 32, Issue 3, 354-356
5
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Druzina A. A. et al. Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates // Mendeleev Communications. 2022. Vol. 32. No. 3. pp. 354-356.
GOST all authors (up to 50) Copy
Druzina A. A., Dudarova N. V., Zhidkova O. B., Razumov I. A., Solovieva O. I., Kanygin V. V., Bregadze V. I. Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates // Mendeleev Communications. 2022. Vol. 32. No. 3. pp. 354-356.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2022.05.021
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.05.021
TI - Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates
T2 - Mendeleev Communications
AU - Druzina, Anna Alexandrovna
AU - Dudarova, Nadezhda Vadimovna
AU - Zhidkova, Olga Borisovna
AU - Razumov, Ivan Alekseevich
AU - Solovieva, Olga Igorevna
AU - Kanygin, Vladimir Vladimirovich
AU - Bregadze, Vladimir Iosifovich
PY - 2022
DA - 2022/04/29
PB - Mendeleev Communications
SP - 354-356
IS - 3
VL - 32
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Druzina,
author = {Anna Alexandrovna Druzina and Nadezhda Vadimovna Dudarova and Olga Borisovna Zhidkova and Ivan Alekseevich Razumov and Olga Igorevna Solovieva and Vladimir Vladimirovich Kanygin and Vladimir Iosifovich Bregadze},
title = {Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates},
journal = {Mendeleev Communications},
year = {2022},
volume = {32},
publisher = {Mendeleev Communications},
month = {Apr},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.05.021},
number = {3},
pages = {354--356},
doi = {10.1016/j.mencom.2022.05.021}
}
MLA
Cite this
MLA Copy
Druzina, Anna Alexandrovna, et al. “Synthesis and cytotoxicity of novel cholesterol–cobalt bis(dicarbollide) conjugates.” Mendeleev Communications, vol. 32, no. 3, Apr. 2022, pp. 354-356. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.05.021.

Keywords

boron cage
boron neutron capture therapy
cancer
cholesterol
cobalt bis(dicarbollide)
cytotoxicity
human glioblastoma U-87 MG
lipids
liposomes

Abstract

The novel conjugates of cholesterol with cobalt – bis(dicarbollide) were synthesized by the ring-opening reactions of the cyclic oxonium derivatives of [3,3′-Co(C2B9H11)2] with the OH group of cholesterol 2-hydroxyethyl ether. The compounds obtained were tested for toxicity to glioblastoma U-87 MG cells and human embryo fibroblasts FECH-15 cells

References

1.
.pi.-Dicarbollyl derivatives of the transition metals. Metallocene analogs
Hawthorne M.F., Young D.C., Andrews T.D., Howe D.V., Pilling R.L., Pitts A.D., Reintjes M., Warren L.F., Wegner P.A.
Journal of the American Chemical Society, 1968
2.
A Theta-Shaped Amphiphilic Cobaltabisdicarbollide Anion: Transition From Monolayer Vesicles to Micelles
Bauduin P., Prevost S., Farràs P., Teixidor F., Diat O., Zemb T.
Angewandte Chemie - International Edition, 2011
3.
Atomistic Simulations of COSAN: Amphiphiles without a Head‐and‐Tail Design Display “Head and Tail” Surfactant Behavior
Malaspina D.C., Viñas C., Teixidor F., Faraudo J.
Angewandte Chemie - International Edition, 2020
4.
Cobalt bis(dicarbollide) anion and its derivatives
Dash B.P., Satapathy R., Swain B.R., Mahanta C.S., Jena B.B., Hosmane N.S.
Journal of Organometallic Chemistry, 2017
5.
Metallacarboranes on the Road to Anticancer Therapies: Cellular Uptake, DNA Interaction, and Biological Evaluation of Cobaltabisdicarbollide [COSAN]−
Fuentes I., García-Mendiola T., Sato S., Pita M., Nakamura H., Lorenzo E., Teixidor F., Marques F., Viñas C.
Chemistry - A European Journal, 2018
6.
Biological interaction of living cells with COSAN-based synthetic vesicles
Tarrés M., Canetta E., Paul E., Forbes J., Azzouni K., Viñas C., Teixidor F., Harwood A.J.
Scientific Reports, 2015
7.
10.1016/j.mencom.2022.05.021_b0035
Spryshkova
Med. Radiol., 1981
8.
Amphiphilic COSAN and I2-COSAN crossing synthetic lipid membranes: planar bilayers and liposomes
Verdiá-Báguena C., Alcaraz A., Aguilella V.M., Cioran A.M., Tachikawa S., Nakamura H., Teixidor F., Viñas C.
Chemical Communications, 2014
9.
Imaging in living cells using νB–H Raman spectroscopy: monitoring COSAN uptake
Tarrés M., Canetta E., Viñas C., Teixidor F., Harwood A.J.
Chemical Communications, 2014
11.
Half- and mixed-sandwich metallacarboranes for potential applications in medicine
Gozzi M., Schwarze B., Hey-Hawkins E.
Pure and Applied Chemistry, 2019
12.
Polyhedral Boranes for Medical Applications: Current Status and Perspectives
Sivaev I.B., Bregadze V.V.
European Journal of Inorganic Chemistry, 2009
13.
10.1016/j.mencom.2022.05.021_b0065
Nakamura
Boron Science: New Technologies and Applications, 2012
14.
Boron clusters-based metallodendrimers
Viñas C., Teixidor F., Núñez R.
Inorganica Chimica Acta, 2014
16.
Towards new boron carriers for boron neutron capture therapy: Metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates
Białek-Pietras M., Olejniczak A.B., Tachikawa S., Nakamura H., Leśnikowski Z.J.
Bioorganic and Medicinal Chemistry, 2013
17.
10.1016/j.mencom.2022.05.021_b0085
Kullberg
Int. J. Oncol., 2003
19.
Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model
Heber E.M., Hawthorne M.F., Kueffer P.J., Garabalino M.A., Thorp S.I., Pozzi E.C., Hughes A.M., Maitz C.A., Jalisatgi S.S., Nigg D.W., Curotto P., Trivillin V.A., Schwint A.E.
Proceedings of the National Academy of Sciences of the United States of America, 2014
22.
Synthesis of novel carboranyl azides and “click” reactions thereof
Stogniy M.Y., Erokhina S.A., Druzina A.A., Sivaev I.B., Bregadze V.I.
Journal of Organometallic Chemistry, 2019
23.
Synthesis of cholesterol derivatives based on closo- and nido-carboranes
24.
25.
Boron-Containing Lipids and Liposomes: New Conjugates of Cholesterol with Polyhedral Boron Hydrides.
Bregadze V.I., Sivaev I.B., Dubey R.D., Semioshkin A., Shmal'ko A.V., Kosenko I.D., Lebedeva K.V., Mandal S., Sreejyothi P., Sarkar A., Shen Z., Wu A., Hosmane N.S.
Chemistry - A European Journal, 2020
26.
Effects of Linkers on the Development of Liposomal Formulation of Cholesterol Conjugated Cobalt Bis(dicarbollides)
Dubey R.D., Sarkar A., Shen Z., Bregadze V.I., Sivaev I.B., Druzina A.A., Zhidkova O.B., Shmal'ko A.V., Kosenko I.D., P S., Mandal S., Hosmane N.S.
Journal of Pharmaceutical Sciences, 2021
27.
Druzina A.A., Shmalko A.V., Andreichuk E.P., Zhidkova O.B., Kosenko I.D., Semioshkin A., Sivaev I.B., Mandal S., Shen Z., Bregadze V.I.
Mendeleev Communications, 2019
28.
Novel Cobalt Bis(dicarbollide) Based on Terminal Alkynes and Their Click‐Reactions
Druzina A.A., Kosenko I.D., Zhidkova O.B., Ananyev I.V., Timofeev S.V., Bregadze V.I.
European Journal of Inorganic Chemistry, 2020
29.
Cyclic oxonium derivatives of cobalt and iron bis(dicarbollides) and their use in organic synthesis
Druzina A.A., Shmalko A.V., Sivaev I.B., Bregadze V.I.
Russian Chemical Reviews, 2021
30.
A Cholesterol Containing pH-Sensitive Bistable [2]Rotaxane
Berg M., Nozinovic S., Engeser M., Lützen A.
European Journal of Organic Chemistry, 2015
31.
Selective Cytotoxicity of Manganese Nanoparticles against Human Glioblastoma Cells
Razumov I.A., Zav’yalov E.L., Troitskii S.Y., Romashchenko A.V., Petrovskii D.V., Kuper K.E., Moshkin M.P.
Bulletin of Experimental Biology and Medicine, 2017
32.
Cytolytic viruses as potential anti-cancer agents
33.
Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin
Pass H.I., Lavilla C., Canino C., Goparaju C., Preiss J., Noreen S., Blandino G., Cioce M.
Oncotarget, 2016